MedPath

BioNTech Diagnostics GmbH

🇩🇪Germany
Ownership
-
Employees
-
Market Cap
-
Website

Re-Examination of Tumor Material and Re-Evaluation of Patient Data From Patients Treated With Neo-adjuvant Therapy

Completed
Conditions
Breast Cancer
Interventions
Device: MammaTyperâ„¢
First Posted Date
2015-05-21
Last Posted Date
2017-01-18
Lead Sponsor
BioNTech Diagnostics GmbH
Target Recruit Count
101
Registration Number
NCT02449993

Re-Evaluation of Tumor Samples From Women With Breast Cancer With the in Vitro Diagnostic Kit "MammaTyperTM"

Not Applicable
Completed
Conditions
Invasive Breast Cancer
Interventions
Device: MammaTyperâ„¢
First Posted Date
2014-09-19
Last Posted Date
2016-11-06
Lead Sponsor
BioNTech Diagnostics GmbH
Target Recruit Count
1010
Registration Number
NCT02244580
© Copyright 2025. All Rights Reserved by MedPath